Abstract
Diabetes is a complex nature. To alleviate this, nutritional intervention provides much scope and hope, and taurine has been placed under this category successfully. An adult human weighing 70 kg contains about 70 g taurine. Taurine in diabetes has an age old story; taurine is involved in the development and protection of insulin apparatus. Taurine and insulin both have mutual stimulating actions with hypoglycemic properties. On the clinical front, taurine supplementation has acceptable beneficial effect in platelet aggregation and to name a few more, in neuropathy, cardiomyopathy, nephropathy and retinopathy. Recent studies have provided a role for taurine in fetal development and also in blocking the transfer of diabetes from diabetic mother to offspring. A number of mechanisms for taurines actions have been advocated, from osmoregulation to anti-oxidation. Though sulfonylurea and recently introduced thiazolidinediones are effective, they are also not free from complications, thus needs to design new therapeutics. As taurine is also a sulfonyl derivative and it will be of great interest to develop taurine analogues as an alternative therapy. Considering the great involvement of taurine in diabetes, this review may provide a holistic view of taurine in diabetes and in its prevention, in this century.
Keywords: Taurine and diabetes
Current Diabetes Reviews
Title: Taurine-Diabetes Interaction: From Involvement to Protection
Volume: 3 Issue: 3
Author(s): Sung-Jin Kim, Ramesh C. Gupta and Hyeon Woo Lee
Affiliation:
Keywords: Taurine and diabetes
Abstract: Diabetes is a complex nature. To alleviate this, nutritional intervention provides much scope and hope, and taurine has been placed under this category successfully. An adult human weighing 70 kg contains about 70 g taurine. Taurine in diabetes has an age old story; taurine is involved in the development and protection of insulin apparatus. Taurine and insulin both have mutual stimulating actions with hypoglycemic properties. On the clinical front, taurine supplementation has acceptable beneficial effect in platelet aggregation and to name a few more, in neuropathy, cardiomyopathy, nephropathy and retinopathy. Recent studies have provided a role for taurine in fetal development and also in blocking the transfer of diabetes from diabetic mother to offspring. A number of mechanisms for taurines actions have been advocated, from osmoregulation to anti-oxidation. Though sulfonylurea and recently introduced thiazolidinediones are effective, they are also not free from complications, thus needs to design new therapeutics. As taurine is also a sulfonyl derivative and it will be of great interest to develop taurine analogues as an alternative therapy. Considering the great involvement of taurine in diabetes, this review may provide a holistic view of taurine in diabetes and in its prevention, in this century.
Export Options
About this article
Cite this article as:
Sung-Jin Kim , Ramesh C. Gupta and Hyeon Woo Lee , Taurine-Diabetes Interaction: From Involvement to Protection, Current Diabetes Reviews 2007; 3 (3) . https://dx.doi.org/10.2174/157339907781368940
DOI https://dx.doi.org/10.2174/157339907781368940 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial [Hot topic: Innate Immunity Molecules S100A8/A9 Involved in Stress Response and Cancer Biology (Guest Editors: Claus Kerkhoff and Saeid Ghavami)]
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Influence of a High-Fat Diet on Cardiac iNOS in Female Rats
Current Vascular Pharmacology Editorial[Hot Topic:Stem Cell Therapy for Cardiovascular Diseases:Are We Still at the Beginning of A Long Road?(Guest Editor:Lino M Goncalves)
Cardiovascular & Hematological Disorders-Drug Targets MicroRNAs Determining Inflammation as Novel Biomarkers and Potential Therapeutic Targets
Current Medicinal Chemistry Mucopolysaccharidosis Type II (Hunter Syndrome): Clinical Picture and Treatment
Current Pharmaceutical Biotechnology Use of BNP and CRP as Biomarkers in Assessing Cardiovascular Disease:Diagnosis Versus Risk
Current Vascular Pharmacology Tracking Stem Cell Therapy in the Myocardium: Applications of Positron Emission Tomography
Current Pharmaceutical Design Immunopathological Aspects of Mycoplasma pneumoniae Infection
Current Pediatric Reviews Bridging the Gap: The Potential Role of Corticosteroid Binding Globulin in Cardiac Steroid Facilitation
Current Drug Targets TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook
Current Drug Targets PET Measurements of cAMP-Mediated Phosphodiesterase-4 with (R)-[11C]Rolipram
Current Radiopharmaceuticals Antiangiogenic Therapy in Malignant Glioma: Promise and Challenge
Current Pharmaceutical Design One Special Question to Start with: Can HIF/NFkB be a Target in Inflammation?
Endocrine, Metabolic & Immune Disorders - Drug Targets ACE2 and Diabetic Complications
Current Pharmaceutical Design Cosignaling Molecules Around LIGHT-HVEM-BTLA: From Immune Activation to Therapeutic Targeting
Current Molecular Medicine Successfully Resuscitated Sudden Cardiac Death in a Young Homosexual Male with HIV Myocarditis
Current HIV Research Editorial from Guest Editor [Hot topic: Novel Inflammatory Biomarkers in Diseases (Guest Editor: Yu Chen)]
Inflammation & Allergy - Drug Targets (Discontinued) Enterovirus D-68 Molecular Virology, Epidemiology, and Treatment: an Update and Way Forward
Infectious Disorders - Drug Targets Decreasing Systemic Toxicity Via Transdermal Delivery of Anticancer Drugs
Current Drug Metabolism Adverse Bioeffects of Ultrasound Contrast Agents Used in Echocardiography: True Safety Issue or “Much Ado About Nothing”?
Current Vascular Pharmacology